A trial to help patients with advanced ovarian cancer plan their visits
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a program to help patients and their doctors work together to set a plan for each visit. If you have advanced ovarian cancer and are getting chemotherapy at Dana-Farber, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You must be able to speak and understand English
- You must have advanced ovarian cancer (stage 3, stage 4, or cancer that has come back)
- You must be getting chemotherapy during the time the study is happening
- You must be willing to sign up for Patient Gateway (an online patient portal)
- You must be willing to have your visits audio recorded
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a specific treatment pathway that may include surgery helps people with advanced ovarian (or related) cancer. It mainly involves planning and undergoing a complex pelvic surgery, sometimes after chemotherapy, to improve outcomes.
This trial tests a combination treatment for advanced ovarian cancer that hasn't been treated before. It combines chemotherapy, a personalized vaccine made from your own immune cells, and a drug called pembrolizumab to help your immune system fight the cancer.
This study looks at ways to help people with advanced cancer or aggressive lymphoma make better treatment decisions with their doctors. If you qualify, you'll be asked to read a short story about a patient in a similar situation and answer questions about your thoughts on care options.
This study tests an educational program to help patients with advanced cancer talk about their goals of care. The goal is to make sure your wishes are known and respected by your care team.
This study tests an approach to help people with certain blood cancers and their main caregiver plan ahead and communicate more clearly about end-of-life care. It may help patients feel more supported and better prepared for difficult decisions.
This study is testing a tool called TA-DA to help patients with advanced cancer and their caregivers make decisions about further treatment after at least two prior therapies. It aims to improve shared decision-making.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.